Clascoterone Cream for Acne

Recruiting in Palo Alto (17 mi)

Age: 18 - 65

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase 4

Waitlist Available

Sponsor: Sun Pharmaceutical Industries Limited

No Placebo Group

Prior Safety Data

Trial Summary

What is the purpose of this trial?to compare facial sebaceous gland morphology after 3 months of clascoterone cream 1% treatment and to compare facial sebum constituents at baseline to facial sebum constituents after 3 months of clascoterone cream 1% treatment

Eligibility Criteria

This trial is for individuals with acne. Specific details about eligibility criteria are not provided, but typically participants must have a certain severity of acne and be in good general health.

Inclusion Criteria

Subjects have signed an Informed Consent Form in compliance with 21CFR Part 50: 'Protection of Human Subjects'

I am in good physical and mental health.

I am between 18 and 35 years old.

+8 more

Exclusion Criteria

I don't have skin conditions that could affect skin evaluation.

I am willing to use the study product on my face as instructed.

Subjects who have history of a psychological illness or condition that would interfere with their ability to understand and follow the requirements of the study

+5 more

Participant Groups

The study is testing the effects of Winlevi (Clascoterone) cream at 1% concentration on facial sebaceous glands and the composition of facial sebum after three months of treatment.

1Treatment groups

Experimental Treatment

Group I: Winlevi (Clascoterone ) cream 1%Experimental Treatment1 Intervention